close

Enter

Log in using OpenID

Orlistat Market

embed
Orlistat is a drug designed to treat obesity. Primary function of Orlistat is to prevent absorption of fat from the diet consumed by humans.
Orlistat Market – Size, Share, Outlook, and
Opportunity Analysis, 2018 – 2026
Orlistat is a drug designed to treat obesity. Primary function of Orlistat is to prevent absorption
of fat from the diet consumed by humans. It prevents absorption of fats by acting as lipase
inhibitors, which eventually reduce the calorie intake. Orlistat works by inhibiting pancreatic
and gastric lipases, pancreatic and gastric enzymes breakdown triglycerides in the intestine.
When activity of lipase is blocked, triglycerides from the diet are not hydrolyzed into
absorbable-free fatty acids, instead remain unchanged. Orlistat also helps in reducing blood
pressure and prevents the onset of type 2 diabetes in obese people. Orlistat medication does not
allow one to regain lost weight and does not block the absorption of fats from non-fat foods
and sugar.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/1878
Orlistat Market drivers:Increasing number of awareness campaigns for weight management is expected to be a major
driver for Orlistat market growth. For instance, in 2013, Roche Holding AG, a pharmaceutical
company, launched its new campaign ‘New You Weight Consciousness Advocacy Campaign’,
with an aim to increase awareness among the populace regarding obesity and its treatment
options. Such awareness campaigns is expected increase the adoption of weight management
medication treatments, which in turn, is expected to boost growth of the Orlistat market size.
Re-launch of Orlistat products is expected to drive the market growth. For instance, in February
2018, H2 Pharma, LLC. partnered with Cheplapharma Arzneimittel GmbH and re-launched
Xenical Capsules, which was acquired from F.Hoffman-La Roche. Xenical capsules were relaunched to increase awareness regarding medication related to weight management, this in
turn, is expected to boost orlistat market growth.
Robust pipeline is expected to boost the market growth over the forecast period. For instance,
orlistat by University of Texas South Western Medical center is in phase 2 since 2015. Orlistat
is used for the treatment of hyperlipoproteinemia type 1. Hyperlipoproteinemia type 1 is caused
due to deficiency of lipoprotein lipase. SLx-4090 by University of Texas South Western Medical
center is in phase 2 to study its effectiveness in combination with Orlistat. SLx-4090 is used to
treat high blood fat level mostly observed in hyperlipoproteinemia type 1 patients.
Rising prevalence of obesity is expected to fuel orlistat market growth. According to a survey
conducted by National Family Health Survey in 2015, in India, over 9.8 million men and over
20 million women were recorded to be obese. India stands second-highest in the world for
obese children, with the number constantly increasing by 3-5 million patients every year.
Orlistat Market Regional Analysis:North America is expected to hold a dominant position in the global orlistat market, owing to
high prevalence of obesity in the region. According to a study conducted by National Institute
of Health in 2016, over 38% of adults aged 20 years and above are obese, over 17.2% of
children aged 7 years and above are obese, and over 30% of the population is considered to be
overweight in the U.S. According to a study conducted by World Health Organization, in 2015,
over 40 million children aged 5 years and above were overweight in the U.S. Thus, high
prevalence of obesity is expected to fuel North America Orlistat market growth over the forecast
period.
Europe Orlistat market is expected to show significant growth due to expected launch of new
generic version of Orlistat over the forecast period. For instance, in 2011, Teva Pharmaceutical
Industries Ltd., launched generic version of Xenical Capsules in the U.K., which was
manufactured by Roche Holding AG. Xenical Capsules is used for the treatment of obesity as
well as for those whose BMI is greater than or equal to 30kg/m 2 and overweight patients. This
in turn, is expected to boost Orlistat market growth, as the drug seems more affordable thus,
being accessible to a large pool of patients.
Report includes chapters which deeply display the following deliverable about industry :
• Orlistat Market Research Objective and Assumption
• Orlistat Market Purview - Report Description, Executive Summary, and Coherent Opportunity
Map (COM)
• Orlistat Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory
Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain
Analysis, Porter’s Analysis, and PEST Analysis
• Global Orlistat Market, By Regions
• Orlistat Market Competition by Manufacturers including Production, Share, Revenue, Average
Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Orlistat Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Orlistat Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of
Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Orlistat Market Forecast including Production, Consumption, Import and Export Forecast by
Type, Applications and Region.
• Research Findings and Conclusion
Orlistat Market Key Players:Key players operating in the Orlistat market include
•
Roche Holding AG
•
GlaxoSmithKline
•
Teva Pharmaceutical Industries Ltd
•
Sandoz Pharmaceuticals
•
STADA–VN J.V. Co. Ltd.
•
Hexal AG.
•
National Company for Pharmaceutical Industry
•
Lunan Pharmaceutical group Corporation Ltd.
•
ZEIN Pharmaceutical Co. Ltd.
•
HISUN Pharmaceuticals Co. Ltd.
•
Taj Pharmaceuticals Ltd.
•
D.M. Pharma
•
China Zhongshan Pharma Co. Ltd.
•
Kabir Life Sciences and Research Pvt. Ltd.
Inquire Here Before Purchase of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1878
Orlistat Market Taxonomy:The global Orlistat market is segmented based on distribution channel and region:
By Distribution channel:• Hospitals/Clinics
• Online Pharmacies
• Retail Pharmacies
By Region:• North America
• Europe
• Latin America
• Asia Pacific
• Middle East
• Africa
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Author
Alex Huge
Alex Huge339   documents Email
Document
Category
Health and Medicine
Views
6
File Size
150 KB
Tags
orlistat, Orlistat Market
1/--pages
Report inappropriate content